| |
| |
|
| Insider
Information: |
Ravina Bernard |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
99,476 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,476 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Voyager Therapeutics, Inc. |
VYGR |
Chief Medical Officer |
2018-04-10 |
0 |
|
0 |
Premium* |
|
|
Praxis Precision Medicines, Inc. |
PRAX |
Chief Medical Officer |
2022-02-12 |
99,476 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRAX |
Praxis Precision Medicine... |
Chief Medical Officer |
• – – |
2022-02-12 |
4 |
D |
$12.85 |
$39,282 |
D/D |
(3,057) |
99,476 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Chief Medical Officer |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
102,533 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Chief Medical Officer |
• – – |
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,512 |
80,533 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Chief Medical Officer |
• – – |
2021-01-04 |
4 |
OE |
$2.27 |
$102,150 |
D/D |
45,000 |
56,021 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Chief Medical OfficerOfficer |
• – – |
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,021 |
|
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2018-04-10 |
4 |
AS |
$18.38 |
$45,049 |
D/D |
(2,451) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2018-03-12 |
4 |
AS |
$25.16 |
$61,667 |
D/D |
(2,451) |
2,451 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2018-02-12 |
4 |
AS |
$18.24 |
$44,706 |
D/D |
(2,451) |
4,902 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2018-01-10 |
4 |
AS |
$16.40 |
$59,532 |
D/D |
(3,630) |
7,353 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-12-11 |
4 |
AS |
$13.63 |
$74,829 |
D/D |
(5,490) |
10,983 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-11-10 |
4 |
AS |
$13.26 |
$72,797 |
D/D |
(5,490) |
16,473 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-10-10 |
4 |
AS |
$20.33 |
$223,223 |
D/D |
(10,980) |
21,963 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-09-11 |
4 |
AS |
$14.30 |
$157,014 |
D/D |
(10,980) |
32,943 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-09-05 |
4 |
AS |
$10.00 |
$54,900 |
D/D |
(5,490) |
17,157 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2017-07-20 |
4 |
AS |
$10.00 |
$54,900 |
D/D |
(5,490) |
49,413 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Medical OfficerOfficer |
• – – |
2017-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
117,647 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
